Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will determine if biomarkers found in the cerebrospinal fluid of people with
Alzheimer's disease, are affected by treatment with two common antibiotics, doxycycline and
rifampicin, suggesting a disease-modifying effect of those treatments.